Schedules of Controlled Substances: Placement of Five Synthetic Cannabinoids Into Schedule I
2012-04-16 2012-04-10 2012-03-12 2012-04-13 2012-03-26
DEA-2012-0001-0014 DEA-2012-0001-0011 DEA-2012-0001-0008 DEA-2012-0001-0013 DEA-2012-0001-0010
04:00:00 04:00:00 04:00:00 04:00:00 04:00:00
https://api.regulations.gov/v4/comments/DEA-2012-0001-0014 https://api.regulations.gov/v4/comments/DEA-2012-0001-0011 https://api.regulations.gov/v4/comments/DEA-2012-0001-0008 https://api.regulations.gov/v4/comments/DEA-2012-0001-0013 https://api.regulations.gov/v4/comments/DEA-2012-0001-0010
Anonymous Elisha Ray Anonymous Gaspare
Anonymous Gray Stout Anonymous Giarraputo
You cannot regulate the people that you claim to represent! enough is enough! when are you going to understand that freedom is not conditional, you cannot have freedom while arresting people for doing what they choose. we will never have peace unless the government ends this power trip and let the people rule themselves. I am a Neuroscientist from MITs Department of Brain and Cognitive Science, and work in the USAs largest neuroscience research facility. I have a deep understanding of pharmacology, and am familiar with exactly how it is that pharmaceutical drugs work, helping save American lives and livelihoods.I suggest that the parties involved with this case DO NOT schedule these cannabinoids as schedule 1 drugs. It has been repeatedly shown in experiments that cannabinoids provide substantial beneficial effects to people who have Parkinsons Disease. This research was further expanded upon in 2010 with additional evidence that cannabinoid receptor agonists (the class of pharmaceutical which these chemicals fall under) can temporarily CURE Parkinsons disease. (Citation: CNS  Neurological Disorders - Drug Targets, 2009, 8, 432-439)I understand that drug abuse is a concern which needs to be addressed. But the very definition of a Schedule 1 drug (no accepted medical use) should be rejected for these compounds, due to the indisputable evidence that these drugs are known to bind to this class of receptor, which has in turn been PROVEN to improve the lives of Americans who are unfortunate enough to be affected by this terrible disorder.Ask yourself, if you or a loved one was unfortunate enough to develop Parkinsons disease, how would you feel knowing that you helped restrict neuroscientists access to these compounds, and blocked research on some of the most promising pharmaceuticals currently under investigation.Other than strongly discouraging research labs to research these chemicals, the additional hundreds of potential pharmaceuticals which are closely chemically related to these ones would NEVER be able to be researched, as scientists will be restricted by analog laws, and will not jump through government hoops for each and every possible unresearched chemical.New cures improve American lives. Listen to the science. Please, do not schedule these compounds. I would respectfully request that this measure be used as a time to re-evaluate the classification of Tetrahydrocannibinol (THC) because this proposal is strictly based upon matching the classification of that substance as a Schedule I drug.  Though I do agree that how these substances were presented and distributed was unethical, It does not mean that the substances should be immediately discounted as having no medical use or highly addictive without reviewing the evidence that determines the parent drugs, THC, classification. The placement of JWH-018, JWH-200, JWH-073, CP-47,497 and cannabicyclohexanol as a Schedule I drugs under the CSA is a good policy choice for public safety, and to prevent abuse. However, I find it useful to further identify whether only these specific combinations or blends  are Schedule I drugs under the CSA, or if each separate component alone is also a Schedule I drug under the CSA. I believe to propose permanently placing these five synthetic cannabinoids as Schedule I drugs under the CSA will only create more work and a need to edit the rule in the future. As technology and science continue to improve, there is always possibility of discovering some medical use for these synthetic cannabinoids and/or their salts and isomers. To classify any drug as a Schedule I drug under the CSA permanently would only create more work for the DEA in the future when new technology may provide the discovery of medical uses.  A good alternative may be to classify these five synthetic cannabinoids and their salts and isomers as Schedule I drugs under the CSA subject to discovery of any and all medical uses by further and future medical and scientific studies and research.    Thank You proposed rule Docket No. DEA-5 should be enacted.we should also stipulate that smoking this chemically treated herb, laughingly sold as incense, is illegal.  